2.6. Safety and Adherence Assessments
ADVERSE EVENTS, CHRONIC KIDNEY DISEASE
The safety endpoint was analyzed using biochemical parameters, adherence, and adverse events. Biochemical parameters were collected using blood, including blood nitrogen urea (BUN), creatinine (Cr), sodium, chloride, potassium, calcium, phosphorus, magnesium, albumin, prealbumin, total protein, C-reactive protein (CRP), cholesterol, triglycerides, uric acid, low-density lipoprotein (LDL), and glycated hemoglobin (HbA1C). The eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula [